Silva-Llanes, I.; Madruga, E.; Martínez, A.; Lastres-Becker, I. "RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection.". Front Neurosci. 18(): 1530809. (2025). (PMID: 39931431).
Silva-Llanes, I.; Rodríguez-López, S.; González-Naranjo, P.; Sastre, E.D.; López, M.G.; Páez, J.A.; Campillo, N.; Lastres-Becker, I. "Targeting CB2 receptor with a novel antagonist reverses cognitive decline, neurodegeneration and pyroptosis in a TAU-dependent frontotemporal dementia mouse model.". Brain Behav Immun. (): . (2025). (PMID: 40081780).
Silva-Llanes, I.; Martín-Baquero, R.; Berrojo-Armisen, A.; Rodríguez-Cueto, C.; Fernández-Ruiz, J.; De Lago, E.; Lastres-Becker, I. "Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia.". Antioxidants (Basel). 13(9): . (2024). (PMID: 39334731).
Silva-Llanes, I.; Shin, C.H.; Jiménez-Villegas, J.; Gorospe, M.; Lastres-Becker, I. "The Transcription Factor NRF2 Has Epigenetic Regulatory Functions Modulating HDACs, DNMTs, and miRNA Biogenesis.". Antioxidants (Basel). 12(3): . (2023). (PMID: 36978889).
Instituto de Investigaciones Biomédicas "Alberto Sols"
C/Arturo Duperier 4. 28029 Madrid. (Spain)
Tel +(34) 91 585 4400 // Fax +(34) 91 558 4401 Email:Info
Email:Info